{"certainAgreement":{"piSponsorEmployee":true},"limitationsAndCaveats":{"description":"Trial closed early after 58 patients were enrolled due to slow accrual and shortage of pegylated liposomal doxorubicin. Only 54 participants had cytogenetics and fluorescence in situ hybridisation (FISH) results available for risk stratification."},"pointOfContact":{"email":"melissa.alsina@moffitt.org","organization":"H. Lee Moffitt Cancer Center and Research Institute","phone":"813-745-6886","title":"Melissa Alsina, M.D."}}